Skip to main content

Sherpa Healthcare Partners — Portfolio, Page 2

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

60
Companies
$952.1M
Total invested
$25.1M
Avg. check
28
Industries
Biotechnology 14Medical 10Health Care 9Pharmaceutical 7Biopharma 6Medical Device 5+22 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 25–48 of 60
Shenji Bio
March 2025

Shenji Bio focuses on the research and development of raw materials such as nucleosides, nucleotides, diagnostic antigens, and antibodies.

Biotechnology · NanjingSeries B
Danking Pharmaceuticals
March 2025

Danatlas is a drug research and development company.

Biopharma · Beijing$20.6M Seed
New Vision Medical
February 2025

New Vision Medical is an IT infrastructure service provider that offers clinical trial-related digital platforms and services.

Information Technology · HangzhouSeries A
Hexaell Biotech
February 2025

Hexaell Biotech is a biopharmaceutical company focused on severe liver disease and cell therapy.

Biotechnology · Shanghai$27.4M Series B
Immunochina
January 2025

Immunochina Pharmaceuticals produces cell injections, cell therapy drugs, and other products and provides medical technology development.

Biotechnology · BeijingSeries E
Kunwei Technology
January 2025

Kunwei Technology manufactures high-precision force sensors (six-axis force sensors) as well as force control systems.

Manufacturing · ChangzhouSeries A
Alebund Pharmaceuticals
January 2025

Alebund Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases.

Biotechnology · Shanghai$75.1M Series C
Wag
July 2024

Wag! is a mobile application used to instantly find trusted and certified dog walkers.

Apps · Mountain View$10.0M Post Ipo Equity
XISOFT
May 2024

XISOFT is a professional manufacturer of informatization and data services in the field of health economic management.

Health Care · ShanghaiSeries C
Cataya Bio
April 2024

Cataya Bio is a synthetic biology startup specializing in the biomanufacturing of chemical and biochemical products.

Biopharma · ShanghaiSeries B
Brattea
March 2024

Brattea is a medical device research and development company.

Health Care · ShanghaiSeries D
ZWI Therapeutics, Inc.
January 2024

ZWI Therapeutics is a biotech company developing a new polymer to reduce immunogenicity and aid pharmacokinetics of protein therapeutics.

Health Care · Cambridge$10.0M Series A
KeChow Pharma
November 2023

KeChow Pharma, Inc. is a biopharmaceutical company focused on novel drug discovery.

Biopharma · PudongSeries Unknown
Lifeshield Medical
October 2023

Lifeshield Medical focuses on life support systems.

Biotechnology · Suzhou$13.7M Series Unknown
MindRank AI
July 2023

MindRank is a clinical stage AI-powered drug discovery company.

Artificial Intelligence (AI) · Shanghai$23.0M Series A
Hongyun Biotech
May 2023

Hongyun Biotech is a biotech company that promotes therapeutic innovation based on structural pharmacology.

Biotechnology · Nanjing$14.4M Series B
BlissBio
January 2023

Bliss Bio is a biopharmaceutical company focused on development of tumor targeting and immunotherapy drugs.

Biopharma · Hangzhou$14.8M Series B
CashBackApp
October 2022

CashBackApp offers you Cash Discounts on a wide range of household essentials available at local supermarkets in Kenya.

E-Commerce · Nairobi$50K Pre-Seed
Insight Lifetech
September 2022

Insight Lifetech is a manufacturer for reliable interventional cardiovascular diagnostic and therapy products.

Health Care · ShenzhenSeries D
Neukio Biotherapeutics
September 2022

Neukio Biotherapeutics is a developer of allogenic immune cell therapies for treatment of cancer.

Biotechnology · Shanghai$50.0M Series A
Yuanyin Bio
June 2022

Yuanyin Bio focuses on the research and application of circular RNA technology.

Biopharma · Haidian$42.0M Series A
Raykol
June 2022

Raykol is a developer of one-stop solutions for laboratory automation in China.

Chemical · Xiamen$14.8M Series A
HuidaGene Therapeutics
May 2022

HuidaGene is a global clinical-stage biotechnology company pioneering innovative gene therapies for neurology and ophthalmology.

Biopharma · ShanghaiSeries C
Belief BioMed
April 2022

Belief BioMed focuses on gene therapy R&D, manufacturing, and clinical applications, specializing in novel AAV vectors.

Biotechnology · Minhang$120.0M Series C

Where Sherpa Healthcare Partners invests

Biotechnology14
Medical10
Health Care9
Pharmaceutical7
Biopharma6
Medical Device5

About Sherpa Healthcare Partners's portfolio

How many companies has Sherpa Healthcare Partners invested in?▸

Sherpa Healthcare Partners has invested in 60 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Sherpa Healthcare Partners invest in?▸

Sherpa Healthcare Partners's top investment sectors include Biotechnology, Medical, Health Care, Pharmaceutical, Biopharma. The firm invests across 28 different industry categories.

What is Sherpa Healthcare Partners's largest investment?▸

Among tracked funding rounds, Belief BioMed received $120.0M in a Series C round. Sherpa Healthcare Partners's total known invested capital is $952.1M.

What is the average investment size for Sherpa Healthcare Partners?▸

Sherpa Healthcare Partners's average investment size is $25.1M across its portfolio of 60 companies.

What are Sherpa Healthcare Partners's most recent investments?▸

Recent Sherpa Healthcare Partners portfolio additions include Shenji Bio, Danking Pharmaceuticals, New Vision Medical, Hexaell Biotech, Immunochina. These companies were founded in 2020 or later.

Reach the founders behind these 60 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →